Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Post by DrJayseron Jan 29, 2021 12:27pm
190 Views
Post# 32420883

Vivamune™ Health Chews joint venture with Mimi’s Rock Corp

Vivamune™ Health Chews joint venture with Mimi’s Rock CorpVivamune™ Health Chews for dogs, previously marketed and sold directly to consumers, now marketed and sold through distributors pursuant to a joint venture with Mimi’s Rock Corp. Dr. Tobias All-In-One Dog Chews, launched on January 23, 2020, directly marketed and sold to consumers through a joint venture with Mimi’s Rock Corp

For the 12 months ended October 31, 2020, sales of each product line were as follows, in Canadian dollars:

Vivamune Health Chews - $28,890


For the 12 months ended October 31, 2019, sales of each product line were as follows, in Canadian dollars:
Vivamune Health Chews - $81,106

<< Previous
Bullboard Posts
Next >>